Skip to content

MEDICELS

Active Private limited companyfounded 2011active for 14 yearsAzalealaan 10, 2950 KapellenKBO/BCE: BE 0842.016.418

Lifetime

14 annual accounts with figures on one time axis
peak of €440,158 in 2025
€440,158▲ 15.1%
peak of €293,305 in 2025
€293,305▲ 9.8%
peak of €1.2m in 2025
€1.2m▲ 10.7%
€747,293▲ 39.4%
Board2 names since 2012
2 directors and 1 other
Documentsfilings and deeds
17-07-202614 days before the deadline
2025micro format
Gross margin from €382,534 to €440,158Dividend €178,876Debts from €536,209 to €747,293Cash from €249,172 to €121,209

Key points

from the 2025 annual accounts

Equity

€1.2m ▲ 10.7%
1.12024+0.3Profit-0.2Dividend1.22025

MEDICELS paid out €178,876 in dividends. That is 61% of the 2025 profit.

Debts

€747,293 ▲ 39.4%
Other debts
+176,937
Taxes and wages
+15,510
Suppliers
+14,319
The rest
+4,318

Debts rose by €211,083 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Position in the sector

€293,305

Higher net result than 95% of companies in retail trade. The sector median is €4,726, over 25,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,817 companies had the same profile as MEDICELS has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,817 companies, not a prediction for MEDICELS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
  • founderdeed of 03-01-2012
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0842016418
appointed as sole director General meeting of 21-11-2023 · Gazette deed
Incorporation Founded by · 100 shares · appointed as sole manager · published on 03-01-2012 · Gazette deed
First establishment Azalealaan 10, Kapellen
All 25 events

Comparable companies

same main activity, similar in size and age
Company
MEDICELS Kapellen €1.9m €440,158 61.2% -
A.R.PHARMA Charleroi €2.1m €399,339 70.8% 1.6
Apotheek Lierseweg Herentals €1.7m €374,818 32.0% 2.5
Oelegem Pharma Ranst €1.8m €541,098 19.1% 2.3
PHARMACIE BAUDOUL-COSSE Namur €1.9m €441,036 23.2% 3.4
APOTHEEK GEEROMS Ninove €1.7m €406,355 46.3% 1.8
Pharmacie Gosselin-Obourg Mons €1.8m €388,077 71.7% 2.1

These companies have the same main activity as MEDICELS: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.7m and €2.1m, founded between 2010 and 2013.

Official details

Source: KBO
Status
Active since 05-12-2011Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.205.668.2512950 Kapellen, since 05-12-2011
Financial year end
31 December
Peppol
Reachable since 20-12-2024
Company details

Annual accounts 2025

≈ €1.6mestimated
€1.9m▲ 20.3%
Filing
Filed on 17-07-2026, 14 days before the end of the filing period
Financials

Insights on MEDICELS

MEDICELS files the micro format. That format states no turnover. The gross margin rose from €138,129 in 2012 to €440,158 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MEDICELS

What is the company number of MEDICELS?
The company number of MEDICELS is 0842.016.418. The VAT number is the same number with BE in front: BE 0842.016.418.
Where is MEDICELS based?
The registered office is at Azalealaan 10, 2950 Kapellen.Company details
What does MEDICELS do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of MEDICELS?
MEDICELS is a private limited company (BV).
When was MEDICELS founded?
MEDICELS was founded on 05-12-2011.
Is MEDICELS still active?
Yes, MEDICELS is an active enterprise in the KBO register.
What is the turnover of MEDICELS?
The turnover in financial year 2025 is about €1.6m. This figure is estimated from the gross margin of €440,158 and 67 comparable companies (NACE 477). It probably lies between €1.1m and €2.5m.Financials
Is MEDICELS profitable?
In financial year 2025, MEDICELS made a profit of €293,305.
Where can I find the annual accounts of MEDICELS?
MEDICELS filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEDICELS due?
MEDICELS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.